Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients
New England Journal of Medicine · 02.03.2023 · 388 (9) · 804-812
DOI: 10.1056/nejmoa2203086 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 02.03.2023. Verfasst von Nicholas C Allen und 44 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, University of Sydney at Royal Prince Alfred Hospital (N.C.A., V.A.S., A.D.G., A.C.C., D.L.D.), the NHMRC (Nationa…. Hauptthemen laut MEDLINE: Niacinamide, Skin Neoplasms, Transplant Recipients, Antineoplastic Agents. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Health and Medical Research Council (NHMRC), NHMRC Practitioner Fellowship, NHMRC Investigator Fellowship.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Dermatology, University of Sydney at Royal Prince Alfred Hospital (N.C.A., V.A.S., A.D.G., A.C.C., D.L.D.), the NHMRC (National Health and Medical Research Council) Clinical Trials Centre, Univers…
ORCID-Profile: Nicholas C Allen, Alexander Tedman, Tom Kovitwanichkanont, Richard A Scolyer
Förderung
- National Health and Medical Research Council (NHMRC)
- NHMRC Practitioner Fellowship
- NHMRC Investigator Fellowship
Zitieren
APA
Allen, N. C., Martin, A. J., Snaidr, V. A., Eggins, R., Chong, A. H., Fernandéz-Peñas, P., Gin, D., Sidhu, S., Paddon, V. L., Banney, L. A., Lim, A., Upjohn, E., Schaider, H., Ganhewa, A. D., Nguyen, J., McKenzie, C. A., Prakash, S., McLean, C., Lochhead, A., …, & Damian, D. L. (2023). Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. New England Journal of Medicine, 388(9), 804-812. https://doi.org/10.1056/nejmoa2203086
Vancouver
Allen NC, Martin AJ, Snaidr VA, Eggins R, Chong AH, Fernandéz-Peñas P, et al. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. New England Journal of Medicine. 2023;388(9):804-812. doi:10.1056/nejmoa2203086
BibTeX
@article{Allen2023,
author = {Allen, Nicholas C and Martin, Andrew J and Snaidr, Victoria A and Eggins, Renee and Chong, Alvin H and Fernandéz-Peñas, Pablo and Gin, Douglas and Sidhu, Shireen and Paddon, Vanessa L and Banney, Leith A and Lim, Adrian and Upjohn, Edward and Schaider, Helmut and Ganhewa, Aparna D and Nguyen, Jennifer and McKenzie, Catriona A and Prakash, Saurabh and McLean, Catriona and Lochhead, Alistair and Ibbetson, Jan and Dettrick, Andrew and Landgren, Anthony and Allnutt, Katherine J and Allison, Clare and Davenport, Rachael B and Mumford, Blake P and Wong, Brittany and Stagg, Brendan and Tedman, Alexander and Gribbin, Hannah and Edwards, Harrison A and De Rosa, Nicholas and Stewart, Thomas and Doolan, Brent J and Kok, Yonatan and Simpson, Kate and Low, Zhi M and Kovitwanichkanont, Tom and Scolyer, Richard A and Dhillon, Haryana M and Vardy, Janette L and Chadban, Steven J and Bowen, David G and Chen, Andrew C and Damian, Diona L},
title = {Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {9},
pages = {804--812},
doi = {10.1056/nejmoa2203086}
}
EUVIMED